Abstract
This retrospective study aims to seek a relationship between the number of thrombotic events and presence of thrombophilic factors in Behcet’s disease (BD). Any patient with a vascular problem evaluated for at least one thrombophilic factor was deemed eligible for the present study. Upon an evaluation of their medical records, 96 (23.9%) of the 402 patients diagnosed with BD were determined to have a history of thrombosis. Of these 96 patients, 72 (75%) had only one thrombotic attack, while the remaining 24 (25%) had two or more thrombotic attacks. Thrombophilic parameters were evaluated in only 36 of the 72 patients (50%) who had one thrombotic event (Group I) and in 18 of the 24 patients (75%) who had more than one thrombotic event (Group II). The patients with recurrent thrombotic events had a significantly higher incidence of combined thrombophilias than those patients with only one thrombotic event (8/18, 44%; 4/36, 11%; p < 0.01). The number of the patients free from thrombophilic risk factors was significantly higher in Group I than in Group II (21/36, 58%; 4/18, 22%; p < 0.02). Group II had an increased frequency of combined thrombophilic risk factors (OR 6.4; 95% CI 1.5–25.8) when compared to Group I. No significant differences were found between Groups I and II with respect to clinical features of BD. In conclusion, combined thrombophilias in patients with BD may have a role in the development of recurrent thrombotic events.
Similar content being viewed by others
References
Lee YJ, Kang SW, Yang JI et al (2002) Coagulation parameters and plasma total homocysteine levels in Behçet’s disease. Thromb Res 106:19–24
Lenk N, Ozet G, Alli N et al (1997) Protein C and protein S activities in Behçet’s disease as risk factors of thrombosis. Int J Dermatol 37:124–125
Leiba M, Sidi Y, Gur H et al (2001) Behçet’s disease and thrombophilia. Ann Rheum Dis 60:1081–1085
Yurdakul S, Yazici H (2008) Behçet’s syndrome. Baillieáre’s Best Pract Res Clin Rheumatol 22:793–809
Leiba M, Seligsohn U, Sidi Y et al (2004) Thrombophilic factors are not the leading cause of thrombosis in Behçet’s disease. Ann Rheum Dis 63:1445–1449
Durieux P, Bletry O, Huchon G, Wechsler B, Chretien J, Godeau P (1981) Multiple pulmonary arterial aneurysms in Behcet’s disease and Hughes-Stovin syndrome. Am J Med 71:736–741
Mammo L, Al-Dalaan A, Bahabri SS, Saour JN (1997) Association of factors V leiden with Behcet’s Disease. J Rheumatol 24:2196–2198
Gül A, Ozbek U, Oztürk C et al (1996) Coagulation factor V gene mutation increases the risk of venous thrombosis in behçet’s disease. Br J Rheumatol 35:1178–1180
Oner AF, Gürgey A, Gürler A, Mesci L (1998) Factor V Leiden mutation in patients with Behçet’s disease. J Rheumatol 25:496–498
Siliagardi M, Ghirarduzzi A, Lori L et al (2001) Factor V leiden and G20210A prothrombin alleles are not associated with thrombosis in Behçet’s disease. Thromb Haemost 85(suppl):2519
Wechsler B, Davatchi F, Hamza M et al (1990) Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s disease. Lancet 335:1078–1080
Hampton KK, Chamberlain MA, Menon DK, Davies JA (1991) Coagulation and fibrinolytic activity in Behçet’s disease. Thromb Haemost 66:292–294
Koşar A, Haznedaroğlu IC, Büyükaşik Y et al (1998) Activated protein C resistance in Behçet’s disease. Rheumatol Int 17:249–250
Toydemir PB, Elhan AH, Tükün A et al (2000) Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet’s disease. J Rheumatol 27:2849–2854
Orem A, Deger O, Memis O et al (1995) Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behcet’s disease. Ann Rheum Dis 54:726–729
Korkmaz C, Kasifoglu T, Kebapcı M (2007) Budd-Chiari syndrome in the course of Behcet’s disease: clinical and laboratory analysis of four cases. Jt Bone Spine 74:245–248
Saadoun D, Rvechsler B, Resche-Rigon M et al (2009) Cerebral venous thrombosis in Behcet’s disease. Arthritis Rheum 61:518–526
de Stefano V, Martinelli I, Mannucci PM et al (1999) The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med 41:801–806
Simioni P, Prandoni P, Lensing AWA et al (1997) The risk of recurrent venous thromboembolism in patients with an Arg506Gln mutation in the gene for factor V (Factor V Leiden). N Engl J Med 336:399–403
Korkmaz C (2008) Is anticoagulation unnecessary in Behcet’s disease with deep venous thrombosis? Clin Rheumatol 27:405–406
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yaşar, N.Ş., Salgür, F., Cansu, D.Ü. et al. Combined thrombophilic factors increase the risk of recurrent thrombotic events in Behcet’s disease. Clin Rheumatol 29, 1367–1372 (2010). https://doi.org/10.1007/s10067-010-1455-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-010-1455-x